First Domestic Biosimilar Products Were Produced

Arven İlaç is able to throw first in Turkey by developping and producing the first biosimilar product. Product helps to prevent “Neutropenia” that mainly hematological side effects of chemotherapy, causes weakening against infections of cancer patients.

HG

Related Post

thumbnail
hover

Obesity in Cancer is More Risky...

To date, nicotine, which is considered to be the main risk factor for cancer, is now being replaced by obesity. Üsküdar University Faculty...

  • Posted by HG
thumbnail
hover

Okan University Hospital Make Free Cancer...

Dr. Tayfun Hancılar oncologist and chief physician at Okan University Hospital went to Bishkek for a free examination of oncology patients ...

  • Posted by HG
thumbnail
hover

Two Software to Facilitate Cancer Diagnosis...

From ITU (İstanbul Technical University) ARI Technopolis companies, Virasoft has developed software that facilitates diagnosis of diseases ...

  • Posted by HG